http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0203920-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd95a181ff623472c64fa16473fbad96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e62e762ed197a74c66a6043cd13574f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
filingDate 2001-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d257dbe607570c0fd4df3912398de5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d9b9b36a3cd738f03633b625d7fb06a
publicationDate 2002-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0203920-A2
titleOfInvention Method for treatment of reactive arthritis or bursitis
abstract An improved method for treatment of conditions in human beings associated with either or both reactive arthritis or bursitis comprising administration of a combination of either acyclovir or valacyclovir with L-lysine, minocycline hydrochloride, and metronidazole. An alternate method comprises administration of isonicotinic acid hydrazide.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1558266-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1558266-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006503095-A
priorityDate 2000-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197776-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5523297-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6034122-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6087382-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128555702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54749604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128931013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129447363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54575046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129322482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129979483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128045545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681276

Total number of triples: 90.